Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 25

1.

BRCA1 is a 220-kDa nuclear phosphoprotein that is expressed and phosphorylated in a cell cycle-dependent manner.

Chen Y, Farmer AA, Chen CF, Jones DC, Chen PL, Lee WH.

Cancer Res. 1996 Jul 15;56(14):3168-72. Erratum in: Cancer Res 1996 Sep 1;56(17):4074.

3.

Cdk2-dependent phosphorylation and functional inactivation of the pRB-related p130 protein in pRB(-), p16INK4A(+) tumor cells.

Cheng L, Rossi F, Fang W, Mori T, Cobrinik D.

J Biol Chem. 2000 Sep 29;275(39):30317-25.

4.

G1 cyclin/cyclin-dependent kinase-coordinated phosphorylation of endogenous pocket proteins differentially regulates their interactions with E2F4 and E2F1 and gene expression.

Calbó J, Parreño M, Sotillo E, Yong T, Mazo A, Garriga J, Grana X.

J Biol Chem. 2002 Dec 27;277(52):50263-74. Epub 2002 Oct 24.

5.

Regulation of E2F transcription by cyclin E-Cdk2 kinase mediated through p300/CBP co-activators.

Morris L, Allen KE, La Thangue NB.

Nat Cell Biol. 2000 Apr;2(4):232-9.

PMID:
10783242
6.

The BRCT domain is a phospho-protein binding domain.

Yu X, Chini CC, He M, Mer G, Chen J.

Science. 2003 Oct 24;302(5645):639-42.

7.
9.

Nuclear localization of cyclin B1 mediates its biological activity and is regulated by phosphorylation.

Li J, Meyer AN, Donoghue DJ.

Proc Natl Acad Sci U S A. 1997 Jan 21;94(2):502-7.

10.
11.

Arrest of the cell cycle by the tumour-suppressor BRCA1 requires the CDK-inhibitor p21WAF1/CiP1.

Somasundaram K, Zhang H, Zeng YX, Houvras Y, Peng Y, Zhang H, Wu GS, Licht JD, Weber BL, El-Deiry WS.

Nature. 1997 Sep 11;389(6647):187-90.

PMID:
9296497
12.

Human carbon catabolite repressor protein (CCR4)-associative factor 1: cloning, expression and characterization of its interaction with the B-cell translocation protein BTG1.

Bogdan JA, Adams-Burton C, Pedicord DL, Sukovich DA, Benfield PA, Corjay MH, Stoltenborg JK, Dicker IB.

Biochem J. 1998 Dec 1;336 ( Pt 2):471-81.

13.

Cell cycle-dependent complex formation of BRCA1.CtIP.MRN is important for DNA double-strand break repair.

Chen L, Nievera CJ, Lee AY, Wu X.

J Biol Chem. 2008 Mar 21;283(12):7713-20. doi: 10.1074/jbc.M710245200. Epub 2008 Jan 2.

14.

Retinoic acid inhibition of cell cycle progression in MCF-7 human breast cancer cells.

Zhu WY, Jones CS, Kiss A, Matsukuma K, Amin S, De Luca LM.

Exp Cell Res. 1997 Aug 1;234(2):293-9.

PMID:
9260897
15.

Distinct phosphorylation events regulate p130- and p107-mediated repression of E2F-4.

Farkas T, Hansen K, Holm K, Lukas J, Bartek J.

J Biol Chem. 2002 Jul 26;277(30):26741-52. Epub 2002 May 2.

16.

Cell cycle regulation of the BRCA1/acetyl-CoA-carboxylase complex.

Ray H, Suau F, Vincent A, Dalla Venezia N.

Biochem Biophys Res Commun. 2009 Jan 16;378(3):615-9. doi: 10.1016/j.bbrc.2008.11.090. Epub 2008 Dec 4.

PMID:
19061860
17.

AP-1 blockade in breast cancer cells causes cell cycle arrest by suppressing G1 cyclin expression and reducing cyclin-dependent kinase activity.

Liu Y, Lu C, Shen Q, Munoz-Medellin D, Kim H, Brown PH.

Oncogene. 2004 Oct 28;23(50):8238-46.

PMID:
15378019
18.
19.

Cyclic AMP-dependent phosphorylation of cyclin D3-bound CDK4 determines the passage through the cell cycle restriction point in thyroid epithelial cells.

Paternot S, Coulonval K, Dumont JE, Roger PP.

J Biol Chem. 2003 Jul 18;278(29):26533-40. Epub 2003 Apr 30.

20.

Supplemental Content

Support Center